Salvador Rico MD, PhD

Sal Rico is Vice President of Clinical Development at Audentes Therapeutics. He is a clinical pharmacologist with 13 years of clinical research experience in the pharmaceutical industry, contract research organizations and academia. He has participated in the design, conduct, and analysis of phase 1-4 clinical trials in multiple therapeutic areas including rare diseases, hematology/oncology, transfusion medicine, psychiatry, sleep medicine, cardiovascular medicine, infectious diseases, pain, allergy, and dermatology.
Prior to joining Audentes he led the clinical development teams at Cerus Corporation and Transcept Pharmaceuticals, and was an investigator at the Centre for Drug Research, Hospital de la Santa Creu i Sant Pau in Barcelona, Spain. His clinical research and development experience includes drugs, biological products and medical devices, such as the INTERCEPT Blood System, INTERMEZZO, HIBOR, CHAMPIX, PROLIA and KERYDIN, among others.
Dr. Rico was awarded a Doctor of Medicine and Surgery degree from the National Autonomous University of Mexico and holds a Masters in Science and a Ph.D. (Summa Cum Laude) in Pharmacology from the Universitat Autonoma de Barcelona. Additionally, he has received postdoctoral training in clinical pharmacology, transfusion medicine (National Autonomous University of Mexico), and pharmaceutical medicine (Universitat Autonoma de Barcelona).